Problemi aziendali e risultati clinici di Novo

Biagio riassume change management, test farmacologici deludenti e impatto sul titolo danese.

Play episode from 06:56

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!